Companies / UCM
USCOM LIMITED
ASX:UCMHealth Care Equipment & Services260.1M shares on issueASX (delayed) · as of 28 July 2026$0.012price · delayed—market cap · indicative
B
Dilution grade
Runway under 2 quarters
Cash runway-0.3 quarters of funding
Share-count growth (24m)4.3%
Raise cadence (24m)0 cash raises
Options & rights overhang0.2% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone
USCOM LIMITED's ordinary share count grew 4.3% between July 2024 and July 2025, to 260M shares. The company did not raise capital in the disclosed 24-month window. Options and rights on issue could convert into 400,000 new shares, equal to 0.2% of the current share count, and 0% are in the money. At the June 2026 quarter the company reported A$-57K in available cash, equivalent to -0.3 quarters of funding at its recent rate. No proposed securities issues (Appendix 3B) are pending.
AI-generated summary of this page's cited filings · updated 28 July 2026
0.2%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
-0.3 qtrs
Cash cover · under 2 quarters
Shares on issue — last 2 years
Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 260.1M per ASX (delayed) (28 July 2026).
Cash runway
-0.3 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$-57k available cash at quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Join the waitlist
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 7 July 2025 | 2A · quoted issue | UCM : ORDINARY FULLY PAID | 260.1M | Appendix 2A |
| 25 Oct 2024 | 3G · unquoted | UCM : ORDINARY FULLY PAID | 250.5M | Appendix 3G |
| 4 Sept 2024 | 2A · quoted issue | UCM : ORDINARY FULLY PAID | 250.5M | Appendix 2A |
| 3 July 2024 | 2A · quoted issue | UCM : ORDINARY FULLY PAID | 249.3M | Appendix 2A |
| 5 Mar 2024 | 2A · quoted issue | UCM : ORDINARY FULLY PAID | 244.6M | Appendix 2A |
Paid plan
Full issuance history
Join the waitlist
Capital raises
No equity raises in the last 24 months.
Paid plan
Full raise history
Join the waitlist
Pending proposed issues
No proposed issues (Appendix 3B) currently pending.
Options & convertible securities
0.2%
Total overhang · of current shares
0.0%
In the money · at current price
400k
Potential new shares
—
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Join the waitlist
Director dealings
| Date | Director | Type | Shares | Options | Value | Source |
|---|---|---|---|---|---|---|
| 7 July 2025 | Robert Allan Phillips | Other | 9.7M | — | — | 3Y notice |
Paid plan
Full dealing history
Join the waitlist
Ownership
Free account
Top-20 holders & substantial holder notices
Sign up free — coming soon
Latest announcements
14 May 2026Final Director's Interest Notice - Bernecker
14 May 2026Director Resignation - Bernecker
27 Nov 2025Results of Meeting
7 Nov 2025Results of Meeting
30 Oct 2025Letter to Shareholders
27 Oct 2025Shareholder letter re AGM
27 Oct 2025Notice of Annual General Meeting/Proxy Form
8 Oct 2025Notice of General Meeting/Proxy Form
26 Sept 2025Corporate Governance Statement
26 Sept 2025Appendix 4G
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.